GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Halberd Corp (OTCPK:HALB) » Definitions » EPS (Basic)

Halberd (Halberd) EPS (Basic) : $ (TTM As of Jul. 2023)


View and export this data going back to 2009. Start your Free Trial

What is Halberd EPS (Basic)?

Halberd's basic earnings per share (Basic EPS) for the six months ended in Jul. 2023 was $-0.00. Halberd does not have enough years/quarters to calculate its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Jul. 2023.

Halberd's EPS (Diluted) for the six months ended in Jul. 2023 was $-0.00. Halberd does not have enough years/quarters to calculate its EPS (Diluted) for the trailing twelve months (TTM) ended in Jul. 2023.

Halberd's EPS without NRI for the six months ended in Jul. 2023 was $-0.00. Halberd does not have enough years/quarters to calculate its EPS without NRI for the trailing twelve months (TTM) ended in Jul. 2023.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.


Halberd EPS (Basic) Historical Data

The historical data trend for Halberd's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Halberd EPS (Basic) Chart

Halberd Annual Data
Trend Jul08 Jul22 Jul23
EPS (Basic)
- - -

Halberd Semi-Annual Data
Jul08 Jul22 Jul23
EPS (Basic) - - -

Halberd EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Halberd's Basic EPS for the fiscal year that ended in Jul. 2023 is calculated as

Basic EPS (A: Jul. 2023 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-0.454-0)/537.108
=-0.00

Halberd's Basic EPS for the quarter that ended in Jul. 2023 is calculated as

Basic EPS (Q: Jul. 2023 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-0.454-0)/537.108
=-0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Halberd  (OTCPK:HALB) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Halberd EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Halberd's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.


Halberd (Halberd) Business Description

Traded in Other Exchanges
N/A
Address
P.O. Box 25, Jackson Center, PA, USA, 16133
Halberd Corp is a research-based biotechnology company seeking to discover and develop medical treatments for a range of diseases. The Company's extracorporeal treatment is designed to treat hard-to-cure blood-borne, neurologic and infectious diseases. The Company's patented methodology removes the appropriate bodily fluid from the patient, in a continuous fashion, like dialysis, or in a batch process, like blood sample testing.
Executives
John Christopher Maddox director, 10 percent owner, officer: President, COO, Treasurer and, other: Interim CFO 10755 VERNON, HUNTINGTON WOODS MI 48070
Mark Sven Lundquist director, 10 percent owner, officer: CEO, Secretary and Director 24655 TUDOR LANE, FRANKLIN MI 48025
Cocco Nicholas A. Jr. director 50104 N. JIMMY COURT, CHESTERFIELD MI 48047-1898
Leland Michael Thomas director 280 LASALLE PLACE, GROSSE POINTE FARMS MI 88236